HPA2b, also known as inactive heparanase-2, is a variant of the heparanase enzyme encoded by the HPSE2 gene. Unlike its active counterpart, HPA2b lacks enzymatic activity and instead plays a role in modulating the function of active heparanase and influencing the composition of the extracellular matrix. The expression of HPA2b is an intricate process regulated by a complex network of cellular mechanisms, including transcriptional control, epigenetic modifications, and signal transduction pathways. Understanding the regulation of HPA2b expression is critical, as it has numerous implications for cellular function and the maintenance of tissue homeostasis.
Several chemical activators have been identified that could potentially induce the expression of HPA2b. Compounds such as retinoic acid, a metabolite of vitamin A, may increase HPA2b transcription by interacting with nuclear retinoic acid receptors. These receptors, upon binding to retinoic acid, form dimers that can bind to retinoic acid response elements located in the promoters of target genes, possibly including HPSE2. Similarly, histone deacetylase inhibitors like Trichostatin A and Sodium butyrate could stimulate HPA2b expression by altering chromatin structure, thus facilitating the access of transcriptional machinery to the HPSE2 gene promoter. By inhibiting histone deacetylase activity, these compounds result in hyperacetylated histones, a marker associated with active transcription. Moreover, DNA-demethylating agents, for instance, 5-Azacytidine, could upregulate HPA2b by removing methyl groups from the DNA, thereby counteracting the repressive effects of methylation on gene expression. Additionally, agents that modulate intracellular signaling cascades, such as Forskolin, which increases cAMP levels, could also play a role in the induction of HPA2b by activating protein kinase A and subsequent transcription factors. These chemical activators represent a diverse array of molecules that, through different mechanisms, all converge on the potential increase in HPA2b levels, highlighting the complexity and interconnectivity of cellular regulatory systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could upregulate HPA2b expression by binding to its nuclear receptors, which then homodimerize or heterodimerize, localize to the nucleus, and initiate transcription of target genes, including potentially HPA2b. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine can lead to the demethylation of the HPSE2 gene promoter, which may result in the increased transcriptional initiation of HPA2b. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could stimulate HPA2b expression by preventing the deacetylation of histones, thereby maintaining an open chromatin conformation around the HPSE2 gene locus, facilitating transcriptional activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin might stimulate HPA2b by elevating cAMP, which in turn activates protein kinase A (PKA) and subsequently phosphorylates transcription factors that upregulate gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate may upregulate HPA2b expression by inhibiting DNA methyltransferases and histone deacetylases, leading to a dual epigenetic modification pattern conducive to gene activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could promote HPA2b expression by inhibiting class I and II histone deacetylases, causing hyperacetylation of histones near the HPSE2 gene promoter, enhancing accessibility for transcription machinery. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol can induce HPA2b expression through its active metabolite, calcitriol, which interacts with vitamin D receptors and binds to vitamin D response elements, increasing transcriptional activity of responsive genes. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea may increase HPA2b expression due to its capacity to induce reactive oxygen species and nitric oxide, which can act as signaling molecules to stimulate the transcription of various genes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride might increase HPA2b expression by inhibiting GSK-3β, leading to the stabilization and activation of transcription factors like β-catenin, which may then upregulate gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could induce HPA2b expression by activating the glucocorticoid receptor, which translocates to the nucleus and binds glucocorticoid response elements to stimulate the transcription of target genes. | ||||||